The average one-year price target for GT Biopharma (NasdaqCM:GTBP) has been revised to 153.00 / share. This is an increase of 2,900.00% from the prior estimate of 5.10 dated January 16, 2024. The ...
The latest price target for GT Biopharma (NASDAQ:GTBP) was reported by Roth MKM on December 2, 2024. The analyst firm set a price target for $11.00 expecting GTBP to rise to within 12 months (a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback